Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer

NCT00041119 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3871

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: AC regimen
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: paclitaxel

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]